12 Mar 2018
There is no “I” in “team”
How the smallest components of life work together to manage our epigenetic inheritance When it comes to understanding the intricate genetic architecture...Read More
28 Dec 2017
What’s next for VAI in 2018
With the end of the year approaching, we asked the Institute’s leadership for a sneak peek into what they are most excited...Read More
30 Nov 2017
Clinical trial investigates possible triple threat for lung cancer
A first-of-its-kind combination of medications may enable the immune system to better combat lung cancer, which claims more lives than any other...Read More
25 Sep 2017
How getting back to the basics can improve human health
When the DNA double helix was first described more than 60 years ago, it sparked a scientific renaissance. It was a revolutionary...Read More
21 Jun 2017
Research brief: Developing a “roadmap” for the second deadliest cancer worldwide
Scientists have a new tool to tackle the second leading cause of cancer death, thanks to work from The Cancer Genome Atlas...Read More
15 Jun 2017
VARI’s Chief Scientific Officer won an Outstanding Investigator Award. Here’s what that means.
VARI’s Chief Scientific Officer Peter Jones, Ph.D., D.Sc., has received a highly competitive 7-year, $7.8 million Outstanding Investigator Award grant from the...Read More
31 May 2017
12 Apr 2017
11 Jan 2017
Making an early impact: Three questions for Dr. Rochelle Tiedemann
The long road from student to independent scientist doesn’t necessarily end with earning a doctoral degree. Just as physicians complete a residency...Read More
17 Nov 2016
Van Andel Research Institute, Cedars-Sinai awarded National Cancer Institute grant for epigenomic data analysis
GRAND RAPIDS, Mich. (Nov. 17, 2016)—Van Andel Research Institute (VARI), in collaboration with Cedars-Sinai, has received a $2.5 million, five-year grant from...Read More